XTLB (xtlbio.com) Bozor qiymatining balans qiymatiga nisbati
XTL Biopharmaceuticals lupus davolashga nisbatan talabning past elastikligi va tayyor ishlanmalarni sotib olish strategiyasi tufayli o'z mahsulotlari bo'yicha sezilarli narx belgilash imkoniyatiga ega. Biznes barqarorligi kompetensiyalari yo'qolishdan himoyalangan, ixcham va yuqori motivatsiyaga ega ekspertlar jamoasi tomonidan ta'minlanadi. Indikator 1.06 darajasida turgan ushbu narxlar grafigi bozor tebranishlarini namoyish etadi, ammo immunologik terapiyaga bo'lgan real talab iqtisodiy sikllardan mustaqil qolmoqda.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_XTLB_-_XTL-Biopharmaceuticals_-_Market-Capitalization-to-Net-Assets "XTLB XTL Bio Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 31.03.2026) | 👁️GURU.Markets👁️")
XTL Biopharmaceuticals Ltd (XTLB) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:XTL Biopharmaceuticals - XTLB
Ushbu koeffitsiyent aktivlarning haddan tashqari sotib olingan holatini baholash va kapital risklarini stress-testdan o'tkazish uchun filtr vazifasini o'taydi. U bozor qiymati va sof aktivlar orasidagi farqni o'lchab, haqiqiy kapitalga nisbatan bozor kutganlarini aks ettiradi. XTL Biopharmaceuticals (XTLB) kompaniyasining nisbiy kapitalizatsiya metriklari tahlili orqali investor balans hisobotiga nisbatan diskont yoki premium darajasini aniqlashi mumkin. Bu XTL Biopharmaceuticals (XTLB) uchun juda muhimdir, chunki shaxsiy laboratoriyalarning yo'qligi uning aktivlarini nomoddiy qilib qo'yadi. Ushbu ko'rsatkichdagi yuqori tebranishlar biznes qiymatining tashqi pudratchilar muvaffaqiyatiga bog'liqligini ta'kidlaydi.
Asosiy raqobatchilar
argenx SE (ARGX) - Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|SVRA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc (RIGL) - Kapitallashuvning sof aktivlarga nisbati|AnaptysBio Inc. (ANAB) - Kapitallashuvning balans qiymatiga nisbati|ATXS - Kapitallashuvning sof aktivlarga nisbati|ENGN (engene.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati Aerovate (JBIO)|Aclaris (ACRS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati Tiziana Life Sciences TLSA|Bozor qiymatining balans qiymatiga nisbati cabalettabio.com CABA|Bozor kapitallashuvining balans qiymatiga nisbati VTYX (Ventyx Biosciences, Inc.)|THTX: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Agenus AGEN|Sof aktivlarga nisbatan bozor kapitallashuvi climbbio.com|Zura Bio (ZURA) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati aTyr Pharma Inc (ATYR)|Bozor kapitallashuvining balans qiymatiga nisbati ADAG (Adagene Inc.)|ImageneBio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Shattuck Therapeutics (STTK)|EQ: Balans qiymatiga nisbatan bozor qiymati|CNTB (connectbiopharm.com) - Bozor qiymatining balans qiymatiga nisbati|Immunic (IMUX) - Kapitallashuvning sof aktivlarga nisbati|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati InflaRx GmbH|Bozor kapitallashuvining balans qiymatiga nisbati XFOR (X4 Pharmaceuticals)|Kapitallashuvning sof aktivlarga nisbati adicetbio.com (ACET)|CELU: Bozor kapitallashuvining balans qiymatiga nisbati|INMB - Bozor qiymatining balans qiymatiga koeffitsiyenti|Barinthus Bio - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences Inc (KZR) - Bozor kapitallashuvining balans qiymatiga nisbati|SABS - Kapitallashuvning sof aktivlarga nisbati|akaritx.com (AKTX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ENLV: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Q32 Bio Corp|Bozor kapitallashuvining balans qiymatiga nisbati GOVX (GeoVax Labs Inc)|Kapitallashuvning sof aktivlarga nisbati Edesa Biotech Corp (EDSA)|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio, Inc.)|Carisma Therapeutics Inc - Bozor kapitallashuvining balans qiymatiga nisbati|BOLT - Bozor qiymatining balans qiymatiga nisbati|HCWB: Bozor qiymatining balans qiymatiga nisbati|aptevotherapeutics.com - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi aimimmuno.com|Kapitallashuvning sof aktivlarga nisbati Aditxt Inc. (ADTX)|Kapitallashuvning balans qiymatiga nisbati gribio.com (GRI)|Kapitallashuvning sof aktivlarga nisbati XORTX Therapeutics|Bozor kapitallashuvining balans qiymatiga multiplikatori HIND (Vyome Holdings Inc.)|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|Bozor qiymatining balans qiymatiga nisbati Indaptus Corp INDP|SCNI - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati affimed.com (AFMD)|Allakos (ALLK) - Sof aktivlarga nisbatan bozor kapitallashuvi|HOOK - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati OCEA (oceanbiomedical.com)|Bozor qiymatining balans qiymatiga nisbati TC BioPharm|Third Harmonic Bio Inc. - Balans qiymatiga nisbatan bozor qiymati